Q2 sales rise 21 percent, but margins narrow and profit growth stays modest
PIDILITIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved unaudited standalone and consolidated results for September 2026. Consolidated Q2 revenue rose 20.9 percent year on year to Rs 4,297.59 crore, while shareholder profit rose 6.1 percent to Rs 614.53 crore. First-half revenue rose 21.1 percent to Rs 8,849.14 crore and shareholder profit rose 18.8 percent to Rs 1,486.94 crore. Margins narrowed year on year. A Rs 14.41 crore exceptional gain came from an associate share swap.
Strong sales growth is positive, but narrower margins and only 6.1 percent Q2 profit growth may cap stock gains.